Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
about
Sequence and analysis of the genome of the pathogenic yeast Candida orthopsilosisCandida-induced prosthetic joint infection. A literature review including 72 cases and a case report.Diversity, in-vitro virulence traits and antifungal susceptibility pattern of gastrointestinal yeast flora of healthy poultry, Gallus gallus domesticusEvaluation of matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry for identification of Candida parapsilosis, C. orthopsilosis and C. metapsilosis.Conserved and divergent roles of Bcr1 and CFEM proteins in Candida parapsilosis and Candida albicans.Influence of culture media on biofilm formation by Candida species and response of sessile cells to antifungals and oxidative stress.Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp.Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.First description of Candida nivariensis in Brazil: antifungal susceptibility profile and potential virulence attributes.The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia.A case of Candida orthopsilosis associated septic arthritis in a patient with Systemic Lupus Erythematosus (SLE)Antifungal Drug Susceptibility of Candida Species Isolated from HIV-Positive Patients Recruited at a Public Hospital in São Luís, Maranhão, Brazil.Antifungal susceptibility of Candida albicans in biofilms.Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella.Epidemiology and risk factors for nosocomial Non-Candida albicans candidemia in adult patients at a tertiary care hospital in North China.Effect of Eugenol on Cell Surface Hydrophobicity, Adhesion, and Biofilm of Candida tropicalis and Candida dubliniensis Isolated from Oral Cavity of HIV-Infected Patients.Characterization of biofilm formation and the role of BCR1 in clinical isolates of Candida parapsilosis.Effect of peritoneal dialysis fluids on activity of echinocandins against Candida spp. biofilm.Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms.Acinetobacter baumannii isolated from hospital-acquired infection: biofilm production and drug susceptibility.Species diversity, antifungal susceptibility and phenotypic and genotypic characterisation of Exophiala spp. infecting patients in different medical centres in Brazil.Efficacy of anidulafungin in the treatment of experimental Candida parapsilosis catheter infection using an antifungal-lock technique.1-n-Hexadecyl-3-methylimidazolium methanesulfonate and chloride salts with effective activities against Candida tropicalis biofilms.Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens.The APSES transcription factor Efg1 is a global regulator that controls morphogenesis and biofilm formation in Candida parapsilosis.Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates.Special issues involving periprosthetic infection in immunodeficiency patientsIn vitro biofilms and antifungal susceptibility of dermatophyte and non-dermatophyte molds involved in foot mycosis.Accurate identification of Candida parapsilosis (sensu lato) by use of mitochondrial DNA and real-time PCR.Analysis of inteins in the Candida parapsilosis complex for simple and accurate species identification.Anticandidal efficacy of cinnamon oil against planktonic and biofilm cultures of Candida parapsilosis and Candida orthopsilosis.Candidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility.Clinical and tree hollow populations of human pathogenic yeast in Hamilton, Ontario, Canada are different.Clinical impact of Candida spp. biofilm production in a cohort of patients with candidemia.In vivo pathogenicity of Trichosporon asahii isolates with different in vitro enzymatic profiles in an immunocompetent murine model of systemic trichosporonosis.Hybridization and emergence of virulence in opportunistic human yeast pathogens.Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical Specimens.Evaluation of in vivo pathogenicity of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis with different enzymatic profiles in a murine model of disseminated candidiasis.Resveratrol, pterostilbene, and baicalein: plant-derived anti-biofilm agents.Candida blankii: an emergent opportunistic yeast with reduced susceptibility to antifungals.
P2860
Q21561002-2C798046-245A-4800-BB56-36FBE45151D9Q30245695-C4EE78D1-DDE4-4119-8BD1-88F5684016A4Q33692141-849FF0F4-C989-4372-A6B9-6FE1DEAF7942Q33891045-985917E4-600A-49AA-A9FA-679D611BCF96Q34092427-38A4215C-DBFB-438D-B0E9-B333289AB971Q35091118-9455E2D3-C02B-44F4-AEC2-1B49907618F1Q35170466-DC76A206-7A1E-46CB-BEF6-219FC2E53082Q35382120-A5187618-E92E-4AA6-99F9-C5256C050366Q36503873-85F01192-DD46-4FA0-AB40-3F08ECA29496Q36683547-5C9ECCED-29FA-435E-8328-5A3D8B380F74Q37009812-F674B3E2-D810-4F54-ACF7-AA1EF64C8C68Q37675406-F0D0559B-5DB8-4A69-9847-F2105EC7DE77Q37906758-DED151D7-1A0E-4058-A7FC-44EDADC70D1CQ38297389-9B7032EA-B134-4712-9981-527E64E016F4Q38558193-83A8253A-EB32-4EEB-A893-45D41982EADCQ38918783-6ADE7F69-6E41-4381-88A5-ADAAB09E4469Q38973069-A5C35F38-ECE7-480A-B646-273075308303Q39526718-90B23E30-9067-4492-A4B9-A11FED4ECFC7Q39767233-7C2E3180-421D-4A7E-81E2-E9D934B3A5FEQ40044406-A6A3380C-8A15-4837-9922-30FADBB3B108Q40352032-9EBCCBB9-5703-42F7-A86D-53FAA067CE6DQ40625328-616E5F35-DC8E-4C3E-89F3-C454C852900BQ41020292-CFC22791-2857-47F8-AE3D-B6BAF4263F48Q41600855-CFD596AC-FE6A-4491-9E2D-D7CB8452BE63Q41911201-353A11DD-64E0-4829-82A7-0D4BB93AF820Q41993568-8ED19396-40B8-40F9-85D8-6667E3A1704EQ41994775-A526FE8B-2C10-4AEE-96C0-4E8FBC898FDEQ41994963-621CF52A-1BA2-4BDC-BC2B-CD7D05C1AE61Q42113240-70893E25-DEF9-47E5-AA8A-E37CED1473A0Q42253102-8231E340-A3DE-4ACA-9CBA-22C276960DE2Q42730616-910DFF7B-ED94-42FC-A7C9-D05B15C56952Q44768623-6EFCF5E0-BF63-4377-B31C-5BBAAB7D360BQ45052854-46272E79-046A-41F0-9C56-13248C1FA6A1Q46243786-3FF07B5B-CC23-4EE8-A4AD-B2B82A994153Q46290651-C6C84E1E-300F-4AE8-BBF6-64A564BEA7D7Q46339999-046EA785-25DA-4A5D-A407-1C2A0A5F8063Q46705972-F2B7E8A5-51CE-40D8-B45E-0CFD333D21D8Q46926417-69240008-E3A1-4905-AA22-0659070E66A2Q54216985-8CD629F6-9D22-4268-8043-301F25B69953Q55383626-C857E74B-A429-4284-8048-1D8C62680FBA
P2860
Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Biofilm production and evaluat ...... Candida parapsilosis complex.
@en
Biofilm production and evaluat ...... Candida parapsilosis complex.
@nl
type
label
Biofilm production and evaluat ...... Candida parapsilosis complex.
@en
Biofilm production and evaluat ...... Candida parapsilosis complex.
@nl
prefLabel
Biofilm production and evaluat ...... Candida parapsilosis complex.
@en
Biofilm production and evaluat ...... Candida parapsilosis complex.
@nl
P2093
P2860
P1433
P1476
Biofilm production and evaluat ...... e Candida parapsilosis complex
@en
P2093
Analy S Melo
Beth A Arthington-Skaggs
Edna Freymüller
Fernando C Bizerra
P2860
P304
P356
10.3109/13693786.2010.530032
P577
2010-11-02T00:00:00Z